Supporting the

Neuroendocrine Cancer Community

NEWS ALERT : MHRA : Co-codamol recall

Jun 17, 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) is supporting a pharmacy/patient level Class 1 National Patient Safety Alert to recall Co-codamol 30/500 Effervescent Tablets (Batch number 1K10121). 

People who use Co-codamol, widely used for pain relief, are being asked to check the batch number on the labels of packs to ensure they are not one of 4,464 (each pack contains 100 tablets) packs which are being recalled due to safety concerns. 

Zentiva Pharma UK Limited is recalling the above product as a precautionary measure as some tablets have been found to potentially have too little of the active ingredients (codeine phosphate and paracetamol) in them which may mean that the medicine does not work as it should do and some tablets may also contain too much of the active ingredients and therefore potentially result in overdose. 

Advice for patients 

If patients have packs which match the label details below, they are advised not to take any further tablets and to return them to their pharmacy for a replacement immediately. 

We would advise concerned patients and the public to speak to their healthcare professional and report any adverse reactions via the Yellow Card scheme. 

 Batch number details : 

• Co-codamol 30/500 Effervescent Tablets 

• Company Name: Zentiva Pharma UK Ltd 

• PL 17780/0046 

• Batch Number: 1K10121 

• Expiry Date: December 2023 

• Pack Size: 100 tablets 

• Batch Size: 4464 packs 

• First Distributed: 05 March 2021 

Further information can be found in the drug alert and press release. 

If you have any queries, please email